NIVOLUMAB IN THE TREATMENT OF REFRACTORY RECURRENT AND METАSTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA. THE RESULTS OF A PHASE III CLINICAL TRIAL (CHECKMATE 141)

A. M. Mudunov

Head and Neck Tumors (HNT)
Opuholi golovy i šei

ISSN 2222-1468 (Print)
ISSN 2411-4634 (Online)

User

eng | рус

Head and Neck Tumors (HNT)

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Mudunov A.M. NIVOLUMAB IN THE TREATMENT OF REFRACTORY RECURRENT AND METАSTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA. THE RESULTS OF A PHASE III CLINICAL TRIAL (CHECKMATE 141). Head and Neck Tumors (HNT). 2017;7(3):74-86. (In Russ.) https://doi.org/10.17650/2222-1468-2017-7-3-74-86

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2222-1468 (Print)
ISSN 2411-4634 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Head and Neck Tumors (HNT)

For citations:

Cookies policy